Use of failure mode and effects analysis in improving the safety of i.v. drug administration

Wayne Adachi1, Amy E Lodolce

  • 1Good Samaritan Hospital, San Jose, CA, USA.

Abstract

Insights

Failure mode and effects analysis (FMEA) reduced intravenous medication errors. Implementing system improvements, including revised order sets and advanced infusion pumps, significantly decreased programming errors.

Area of Science:

  • Healthcare quality improvement
  • Patient safety research
  • Clinical pharmacy practice

Background:

  • Medication errors, particularly dosing and administration errors with intravenous (i.v.) medications, pose a significant risk to patient safety.
  • Wrong-dose errors constituted 17% of all medication errors in 2002, with i.v. infusion pump programming errors being the most frequent cause (41%).

Purpose of the Study:

  • To utilize Failure Mode and Effects Analysis (FMEA) to identify potential dosing and administration errors associated with i.v. medications.
  • To evaluate the effectiveness of system improvements implemented to reduce these medication errors.

Main Methods:

  • A multidisciplinary medication safety team conducted an FMEA to pinpoint critical failure points in the i.v. medication administration process.
  • Interventions included revising standard i.v. order sets and implementing i.v. infusion pumps with enhanced safety features.

Main Results:

  • The FMEA identified several potential errors, including misinterpretation of orders and incorrect programming of i.v. infusion pumps, with pump programming identified as having the highest criticality index.
  • Following interventions, overall dosing errors decreased slightly, but pump-related errors saw a significant reduction from 41% in 2002 to 22% in 2003.

Conclusions:

  • Conducting an FMEA is an effective strategy for identifying and mitigating medication errors related to i.v. infusion pumps.
  • System-level changes, such as improved order sets and advanced technology, can substantially enhance medication safety and reduce administration errors.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...